NLRP3 and immune system disorder: Altogether, this study showed a novel effect of ODZ for the regulation of NLRP3 inflammasome activation in vitro and in vivo, suggesting its potential for use in treating NLRP3-inflammasome-mediated immune disorders and cancer.